Understanding the New Findings Triple-negative breast cancer (TNBC) remains a challenging subtype of breast cancer, characterized by the absence of estrogen, progesterone, and HER2 receptors. This makes targeted hormonal therapies ineffective, driving interest in combination approaches such as neoadjuvant chemotherapy paired with immunotherapy. Recent research suggests that magnetic resonance imaging (MRI) could play a pivotal…